ArticleESC heart failure2020

Efficacy of phosphodiesterase type 5 inhibitors in univentricular congenital heart disease: the SV-INHIBITION study design.

Pascal Amedro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.